Skip to main navigation Skip to search Skip to main content

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0

  • Wolfgang P. Fendler
  • , Matthias Eiber
  • , Mohsen Beheshti
  • , Jamshed Bomanji
  • , Francesco Ceci
  • , Steven Cho
  • , Frederik Giesel
  • , Uwe Haberkorn
  • , Thomas A. Hope
  • , Klaus Kopka
  • , Bernd J. Krause
  • , Felix M. Mottaghy
  • , Heiko Schoder
  • , John Sunderland
  • , Simon Wan
  • , Hans-Juergen Wester
  • , Stefano Fanti
  • , Ken Herrmann*
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The aim of this guideline is to provide standards for the recommendation, performance, interpretation and reporting of Ga-68-PSMA PET/CT for prostate cancer imaging. These recommendations will help to improve accuracy, precision, and repeatability of Ga-68-PSMA PET/CT for prostate cancer essentially needed for implementation of this modality in science and routine clinical practice.

Original languageEnglish
Pages (from-to)1014-1024
Number of pages11
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume44
Issue number6
DOIs
Publication statusPublished - Jun 2017

Keywords

  • PSMA
  • PET
  • Prostate cancer
  • Staging
  • Restaging
  • Guideline
  • MEMBRANE ANTIGEN-EXPRESSION
  • TUMOR-ASSOCIATED NEOVASCULATURE
  • GA-68-LABELED PSMA LIGAND
  • RENAL-CELL CARCINOMA
  • RADIATION-DOSIMETRY
  • RADIOLIGAND THERAPY
  • HBED-CC
  • ANDROGEN RECEPTOR
  • BIODISTRIBUTION
  • INHIBITOR

Fingerprint

Dive into the research topics of '68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0'. Together they form a unique fingerprint.

Cite this